Tumor promoters - microcystin-LR, nodularin and TNF-α and human cancer development

Anti-Cancer Agents in Medicinal Chemistry

Volumn 11, Issue 1, 2011, Pages 4-18

  Fujiki, Hirota ^a   Suganuma, Masami ^b  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b SAITAMA CANCER CENTER   (Japan)

Author keywords

Apparent activation of protein kinases; Liver carcinogenesis; Microcystin LR; Nodularin; Okadaic acid; Protein phosphatases 1 and 2A; Tumor necrosis factor ; Tumor promotion

Indexed keywords

DIETHYLNITROSAMINE; INTERLEUKIN 1; MICROCYSTIN LR; NODULARIN; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR PROMOTER;

APOPTOSIS; CARCINOGENESIS; CARCINOGENICITY; CRYSTAL STRUCTURE; ENZYME INHIBITION; GENE EXPRESSION; RECEPTOR BINDING; REVIEW; STOMACH CANCER; TUMOR PROMOTION;

EID: 79953011853     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152011794941163     Document Type: Review

References (125)

1. Fujiki, H.; Moore, R.E. U.S.-Japan seminar on marine natural products and cancer chemoprevention. Jpn. J. Cancer Res. (Gann), 1987, 78, 875-878.
2. Tachibana, K.; Scheuer, P.J.; Tsukitani, Y.; Kikuchi, H.; Van Engen, D.; Clardy, J; Gopichand, Y.; Schmitz, F.J. Okadaic acid, a cytotoxic polyether from two marine sponges of the genus Halichondria. J. Am. Chem. Soc., 1981, 103, 2469-2471.
3. Hecker, E. Phorbol esters from croton oil, chemical nature and biological activities. Naturwissenschaften, 1967, 54, 282-284.
4. Nishizuka, Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature, 1983, 308, 693-698.
5. Suganuma, M.; Fujiki, H.; Suguri, H.; Yoshizawa, S.; Hirota, M.; Nakayasu, M.; Ojika, M.; Wakamatsu, K.; Yamada, K.; Sugimura, T. Okadaic acid: an additional non-phorbol-12-tetradecanoate-13- acetate-type tumor promoter. Proc. Natl. Acad. Sci. USA, 1988, 85, 1768-1771.
6. Boutwell, R.K. The Role of the Induction of Ornithine Decarboxylase in Tumor Promotion. In Origins of Human Cancer, Hiatt, H.H., Watson, J.D., Winsten, J.A.; Eds.; Cold Spring Harbor Laboratory: Cold Spring Harbor NY, 1977; pp. 773-783.
7. Carmichael, W.W. Cyanobacteria secondary metabolites the cyanotoxins. J. Appl. Bacteriol., 1992, 72, 445-459.
8. Harada, K.-I.; Matsuura, K.; Suzuki, M.; Oka, H.; Watanabe, M.F.; Oishi, S.; Dahlem, A.M.; Beasley, V.R.; Carmichael, W.W. Chemical analysis of toxic peptides from cyanobacteria by reversed phase high performance liquid chromatography. J. Chromatogr., 1988, 448, 275-283.
9. Watanabe, M.F.; Ohishi, S.; Harada, K.-I.; Matsuura, K.; Kawai, H.; Suzuki, M. Toxins contained in Microcystis species of cyanobacteria (blue-green algae). Toxicon, 1988, 26, 1017-1025.
10. Yoshizawa, S.; Matsushima, R.; Watanabe, M.F.; Harada, K-I.; Ichihara, A.; Carmichael, W.W.; Fujiki, H. Inhibition of protein phosphatases by microcystin and nodularin associated with hepatotoxicity. J. Cancer Res. Clin. Oncol., 1990, 116, 609-614.
11. Fujiki, H.; Suganuma, M. Tumor Promotion by Inhibitors of Protein Phosphatases 1 and 2A: the Okadaic Acid Class of Compounds. In Adv. Cancer Res., Vande Woude, G.F., Klein, G., Eds.; Academic Press Inc: London, 1993, vol. 61, pp. 143-194.
12. Fujiki, H.; Sueoka, E.; Suganuma, M. Carcinogenesis of Microcystins. In Toxic Microcystis, Watanabe, M.F., Harada, K.-I., Carmichael, W.W., and Fujiki, H., Eds.; CRC Press Inc: Boca Raton, Florida, 1995, pp. 203-232.
13. Fujiki, H.; Suganuma, M. Naturally-derived tumor promoters and inhibitors of carcinogenesis. J. Toxicol.- Toxin. Rev., 1996, 15(2), 129-156.
14. Nishiwaki-Matsushima, R.; Ohta, T.; Nishiwaki, S.; Suganuma, M.; Kohyama, K.; Ishikawa, T.; Carmichael, W.W.; Fujiki, H. Liver tumor promotion by the cyaobacterial cyclic peptide toxin microcystin-LR. J. Cancer Res. Clin. Oncol., 1992, 118, 420-424.
15. Ohta, T.; Sueoka, E.; Iida, N.; Komori, A.; Suganuma, M.; Nishiwaki, R; Tatematsu, M.; Kim, S-J.; Carmichael, W.W.; Fujiki, H. Nodularin, a potent inhibitor of protein phosphatases 1 and 2A, is a new environmental carcinogen in male F344 rat liver. Cancer Res., 1994, 54, 6402-6406.
16. Honkanen, R.E.; Dukelow, M.; Zwiller, J.; Moore, R.E.; Khatra, B.S.; Boynton, A.L. Cyanobacterial nodularin is a potent inhibitor of type 1 and type 2A protein phosphatases. Mol. Pharmacol., 1991, 40, 577-583.
17. de Silva, E.D.; Williams, D.E.; Andersen, R.; Klix, H.; Holmes, C.F.B.; Allen, T.M. Motuporin, a potent protein phosphatase inhibitor isolated from the Papua New Guinea sponge Theonella swinhoei gray. Tetrahedron Lett., 1992, 33, 1561-1564.
18. Old, L. J. Tumor necrosis factor (TNF). Science, 1985, 230, 630-632.
19. Komori, A.; Yatsunami, J.; Suganuma, M.; Okabe, S.; Abe, S.; Sakai, A.; Sasaki, K.; Fujiki, H. Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation. Cancer Res., 1993, 53, 1982-1985.
20. Fujiki, H.; Suganuma, M. Tumor necrosis factor-α, a new tumor promoter, engendered by biochemical studies of okadaic acid. J. Biochem., 1994, 115, 1-5.
21. Grosse, Y., Baan, R.; Strait, K.; Secretan, B.; Ghissassi F.E.I.; Cogliano, V. Carcinogenicity of nitrate, nitrite, and cyanobacterial peptide toxins. Lancet Oncol., 2006, 7, 628-629.
22. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Ingested Nitrate and Nitrite, and Cyanobacterial Peptide Toxins. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, IARC: Lyon, 2010, vol. 94, pp. 327-357.
23. Fujiki, H.; Suganuma, M. Carcinogenic Aspects of Protein Phosphatase 1 and 2A Inhibitors. In Marine Toxins as Research Tools, Fusetani, N., Kem, W., Eds.; Springer: Berlin Heidelberg, 2009, pp. 221-254.
24. Uemura, D.; Hirata, Y. Antitumor Polyethers from Marine Animals. In Studies in Natural Products Chemistry, Rahman, A.U., Ed.; Elsevier: Amsterdam, 1989, pp. 377-401.
25. Suganuma, M.; Suttajit, M.; Suguri, H.; Ojika, M.; Yamada, K.; Fujiki, H. Specific binding of okadaic acid, a new tumor promoter in mouse skin. FEBS Lett., 1989, 250, 615-618.
26. Sassa, T.; Richter, W.W; Uda, N.; Suganuma, M.; Suguri, H.; Yoshizawa, S.; Hirora, M.; Fujiki, H. Apparent activation of protein kinases by okadaic acid class tumor promoters. Biochem. Biophys. Res. Commun., 1989, 159, 939-944.
27. Takai, A.; Bialojan, C.; Troschka, M.; Rüegg, J.C. Smooth muscle myosin phosphatase inhibition and force enhancement by black sponge toxin. FEBS Lett., 1987, 217, 81-84.
28. Erdödi, F.; Rokolya, A.; DiSalvo, J.; Bárány, M.; Bárány, K. Effect of okadaic acid on phosphorylation-dephosphorylation of myosin light chain in aortic smooth muscle homogenate. Biochem. Biophys. Res. Commun., 1988, 153, 156-161.
29. Haystead, T.A.J.; Sim, A.T.R.; Carling, D.; Honnor, R.C., Tsukitani, Y.; Cohen, P.; Hardie, D.G. Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism. Nature, 1989, 337, 78-81.
30. MacKintosh, C.; Beattie, K.A.; Klumpp, S.; Cohen, P.; Codd, G.A. Cyanobacterial microcystin-LR is a potent and specific inhibitor of protein phosphatases 1 and 2A from both mammals and higher plants. FEBS Lett., 1990, 264, 187-192.
31. Craig, M.; McCready, T.L.; Luu, H.A.; Smillie, M.A.; Dubord, P.; Holmes, C.F.B. Identification and characterization of hydrophobic microcystins in Canadian freshwater cyanobacteria. Toxicon, 1993, 31, 1541-1549.
32. Murata, M.; Shimatani, M.; Sugitani, H.; Oshima, Y.; Yasumoto, T. Isolation and structural elucidation of the causative toxin of the diarrhetic shellfish poisoning. Bull. Jpn. Soc. Sci. Fish, 1982, 48, 549-552.
33. Kato, Y.; Fusetani, N.; Matsunaga, S.; Hashimoto, K.; Fujita, S.; Furuya, T.J. Calyculin A, a novel antitumor metabolite from the marine sponge Discodermia calyx. J. Am. Chem. Soc., 1986, 108, 2780.
34. Brautigan, D.L.; Shinder, C.L. Methods to Distinguish Various Types of Protein Phosphatase Activity. In Methods in Enzymology, Gorbin, J., Johnson, R., Eds.; Academic Press: San Diego, 1988, vol. 159, pp. 339-346.
35. Suganuma, M.; Fujiki, H.; Okabe, S.; Nishiwaki, S.; Brautigan, D.; Ingebritsen, T.S.; Rosner, M.R. Structurally different members of the okadaic acid class selectively inhibit protein serine/threonine but not tyrosine phosphatase activity. Toxicon, 1992, 30, 873-878.
36. Ingebritsen, T.S. Resolution and Characterization of Multiple protein-Tyrosine phosphatase Activities. In Methods in Enzymology, Hunter, T., Sefton, B., Eds.; Academic Press: San Diego, 1991, vol. 201, pp. 451-465.
37. Fujiki, H. Is the inhibition of protein phosphatase 1 and 2A activities a general mechanism of tumor promotion in human cancer development? Mol. Carcinog, 1992, 5, 91-94.
38. Matsushima, R.; Yoshizawa, S.; Watanabe, M.F.; Harada, K.-I.; Furusawa, M.; Carmichael, W.W.; Fujiki, H. In vitro and in vivo effects of protein phosphatase inhibitors, microcystins and nodularin, on mouse skin and fibroblasts. Biochem. Biophys. Res. Commun., 1990, 171, 867-874.
39. Eriksson, J.E.; Grönberg, L.; Nygård, S.; Slotte, J.P.; Meriluoto, J.A.O. Hepatocellular uptake of 3H-dihydromicrocystin-LR, a cyclic peptide toxin. Biochim. Biophys. Acta, 1990, 1025, 60-66.
40. McDermott, C.M.; Nho, C.W.; Howard, W.; Holton, B. The cyanobacterial toxin, microcystin-LR, can induce apoptosis in a variety of cell types. Toxicon, 1998, 36, 1981-1996.
41. Yatsunami, J.; Fujiki, H.; Suganuma, M.; Yoshizawa, S.; Eriksson, J.E.; Olson, M.O.J.; Goldman, R.D. Vimentin is hyperphosphorylated in primary human fibroblasts treated with okadaic acid. Biochem. Biophys. Res. Commun.,1991, 177, 1165-1170.
42. Eriksson, J.E.; Brautigan, D.L.; Vallee, R.; Olmsted, J.; Fujiki, H.; Goldman, R.D. Cytoskeletal integrity in interphase cells requires protein phosphatase activity. Proc. Natl. Acad. Sci. USA, 1992, 89, 11093-11097.
43. Nishiwaki, R.; Ohta, T.; Sueoka, E.; Suganuma, M.; Harada, K.-I.; Watanabe, M.F.; Fujiki, H. Two significant aspects of microcystin- LR: specific binding and liver specificity. Cancer Lett., 1994, 83, 283-289.
44. Lin, J.-R.; Chu, F.S. Kinetics of distribution of microcystin LR in serum and liver cytosol of mice: An immunochemical analsis. J. Agric. Food Chem., 1994, 42, 1035-1040.
45. Robinson, N.A.; Pace, J.G.; Matson, C.F.; Miura, G.A.; Lawrence, W.B. Tissue distribution, excretion and hepatic biotransformation of microcystin-LR in mice. J. Pharmacol. Exp. Ther., 1991, 256, 176-182.
46. Ohta, T.; Nishiwaki, R.; Yatsunami, J.; Komori, A.; Suganuma, M.; Fujiki, H. Hyperphosphorylation of cytokeratins 8 and 18 by microcystin- LR, a new liver tumor promoter, in primary cultured rat hepatocytes. Carcinogenesis., 1992, 13, 2443-2447.
47. Harada, K.-I.; Ogawa, K.; Matsuura, K.; Murata, H.; Suzuki, M.; Watanabe, M.F.; Itezono Y.; Nakayama, N. Structural determination of geometrical isomers of microcystins LR and RR from cyanobacteria by two-dimensional NMR spectroscopic techniques. Chem. Res. Toxicol., 1990, 3, 473-481.
48. Nishiwaki-Matsushima, R.; Nishiwaki, S.; Ohta, T.; Yoshizawa, S.; Suganuma, M.; Hatada, K.-I.; Watanabe, M.F.; Fujiki, H. Structure- function relationships of microcystins, liver tumor promoters, in interaction with protein phosphatase. Jpn. J. Cancer Res., 1991, 82, 993-996.
49. Nishiwaki-Matsushima, R.; Fujiki, H.; Harada, K.-I.; Taylor C.; Quinn, R.J. The role of arginine in interactions of microcystins with protein phosphatases 1 and 2A. Bioorg. Med. Chem., 1992, 2, 673-676.
50. Goldberg, J.; Huang, H.-b.; Kwon, Y.-g.; Greengard, P.; Nairn, A.C.; Kuriyan J. Three-dimensional structure of the catalytic subunit of protein serine/threonine phosphatase-1. Nature, 1995, 376, 745-753.
51. Egloff, M.-P.; Cohen, P.T.W.; Reinemer, P.; Barford, D. Crystal structure of the catalytic subunit of human protein phosphatase 1 and its complex with tungstate. J. Mol. Biol., 1995, 254, 942-959.
52. Xing, Y.; Xu, Y.; Chen, Y.; Jeffrey, P.D.; Chao, Y.; Lin, Z.; Li, Z.; Strack, S.; Stock, J.B.; Shi, Y. Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins. Cell, 2006, 127, 341-353.
53. Bagu, J.R.; Sykes, B.D.; Craig, M.M.; Holmes, C.F.B. A molecular basis for different interactions of marine toxins with protein phosphatase-1. Molecular models for bound motuporin, microcystins, okadaic acid, and calyculin A. J. Biol. Chem., 1997, 272, 5087-5097.
54. Runnegar, M.; Berndt, N.; Kong, S.-M.; Lee, E.Y.C.; Zhang, L. In vivo and in vitro binding of microcystin to protein phosphatases 1 and 2A. Biochem. Biophys. Res. Commun.,1995, 216, 162-169.
55. Xu, Y.; Xing, Y.; Chao, Y.; Lin, Z.; Fan, E.; Yu, J.W.; Strack, S.; Jeffrey, P.D.; Shi, Y. Structure of the protein phosphatase 2A holoenzyme. Cell, 2006, 127, 1239-1251.
56. Maynes, J.T.; Luu, H.A.; Cherney, M.M.; Andersen, R.L.; Williams, D.; Holmes, C.F.B.; James, M.N.G. Crystal structures of protein phosphatase-1 bound to motuporin and dihydromicrocystin- LA: elucidation of the mechanism of enzyme inhibition by cyanobacterial toxins. J. Mol. Biol., 2006, 356, 111-120.
57. Rao, P.V.L.; Bhattacharya, R. The cyanobacterial toxin microcystin- LR induced DNA damage in mouse liver in vivo. Toxicology, 1996, 114, 29-36.
58. Gupta, N.; Pant, S.C.; Vijayaraghavan, R.; Rao, P.V.L. Comparative toxicity evaluation of cyanobacterial cyclic peptide toxin microcystin variants (LR, RR, YR) in mice. Toxicology, 2003, 188, 285-296.
59. Maatouk, I.; Bouaïcha, N.; Plessis, M.J.; Périn, F. Detection by 32P-postlabelling of 8-oxo-7,8-dihydro-2-deoxyguanosine in DNA as biomarker of microcystin-LR- and nodularin-induced DNA damage in vitro in primary cultured rat hepatocytes and in vivo in rat liver. Mutat. Res., 2004, 564, 9-20.
60. Bouaïcha, N.; Maatouk, I.; Plessis, M.-J.; Périn, F. Genotoxic potential of microcystin-LR and nodularin in vitro in primary cultured rat hepatocytes and in vivo in rat liver. Environ. Toxicol., 2005, 20(3), 341-347.
61. Žegura, B.; Sedmak, B.; Filipič, M. Microcystin-LR induces oxidative DNA damage in human hepatoma cell line HepG2. Toxicon, 2003, 41, 41-48.
62. Žegura, B.; Sedmak, B.; Filipič, M. The role of reactive oxygen species in microcystin-LR-induced DNA damage. Toxicology, 2004, 200, 59-68.
63. Bouaïcha, N.; Maatouk, I. Microcystin-LR and nodularin induce intracellular glutathione alteration, reactive oxygen species production and lipid peroxidation in primary cultured rat hepatocytes. Toxicol. Lett., 2004, 148, 53-63.
64. Zhan, L.; Sakamoto, H.; Sakuraba, M.; Wu, D.-S.; Zhang, L.-S.; Suzuki, T.; Hayashi, M.; Honma, M. Genotoxicity of microcystin- LR in human lymphoblastoid TK6 cells. Mutat. Res. 2004, 557, 1-6.
65. Humpage, A.R.; Falconer, I.R. Microcystin-LR and liver tumor promotion: effects on cytokinesis, ploidy, and apoptosis in cultured hepatocytes. Environ. Toxicol., 1999, 14, 61-75.
66. Nobre, A.C.L.; Coêlho, G.R.; Coutinho, M.C.M.; Silva, M.M.M.; Angelim, E.V. Menezes, D.B.; Fonteles, M.C.; Monteiro, H.S.A. The role of phospholipase A2 and cyclooxygenase in renal toxicity induced by microcystin-LR. Toxicon, 2001, 39, 721-724.
67. Mankiewicz, J.; Tarczynska, M., Fladmark, K.E.; Doskeland, S.O.; Walter, Z.; Zalewski, M. Apoptotic effect of cyanobacterial extract on rat hepatocytes and human lymphocytes. Environ. Toxicol., 2001, 16(3), 225-233.
68. Lankoff, A.; Banasik, A.; Obe, G.; Deperas, M.; Kuzminski, K.; Tarczynska, M.; Jurczak, T.; Wojcik, A. Effect of microcystin-LR and cyanobacterial extract from Polish reservoir of drinking water on cell cycle progression, mitotic spindle, and apoptosis in CHOK1 cells. Toxicol. Appl. Pharmacol., 2003, 189, 204-213.
69. Botha, N.; Gehringer, M.M.; Downing, T.G.; van de Venter, M.; Shephard, E.G. The role of microcystin-LR in the induction of apoptosis and oxidative stress in CaCo2 cells. Toxicon, 2004, 43, 85-92.
70. Holladay, K.; Fujiki, H.; Bowden, G.T. Okadaic acid induces the expression of both early and secondary response genes in mouse keratinocytes. Mol. Carcinogen., 1992, 5, 16-24.
71. Kim, S.-J.; Kim, K.Y.; Tapscott, S.J.; Winokur, T.S.; Park, K.; Fujiki, H.; Weintraub, H.; Robert, A.B. Inhibition of protein phosphatases blocks myogenesis by first altering MyoD binding activity. J. Biol. Chem., 1992, 267, 15140-15145.
72. Thévenin, C.; Kim, S.-J.; Kehrl, J.H.; Inhibition of protein phosphatases by okadaic acid induces AP1 in human T cells. J. Biol. Chem., 1991, 266, 9363-9366.
73. Sen, R.; Baltimore, D. Inducibility of kappa immunoglobulin enhancer- binding protein NF-kappa B by a posttranslational mechanism. Cell, 1986, 47, 921-928.
74. Sueoka, E.; Sueoka, N.; Okabe, S.; Kozu, T.; Komori, A.; Ohta, T.; Suganuma, M.; Kim, S.-J.; Lim, I.K.; Fujiki, H. Expression of the tumor necrosis factor α gene and early response genes by nodularin, a liver tumor promoter, in primary cultured rat hepatocytes. J. Cancer Res. Clin. Oncol., 1997, 123, 413-419.
75. Hilberg, F.; Aguzzi, A.; Howells, N.; Wagner, E.F. c-jun is essential for normal mouse development and hepatogenesis. Nature, 1993, 365, 179-181.
76. Angel, P.; Karin, M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta, 1991, 1072, 129-157.
77. Sueoka, E.; Sueoka, N.; Komori, A.; Okabe, S., Kozu, T.; Suganuma, M.; Fujiki, H. Expression of Early Response Genes by Nodularin, a New Liver Carcinogen, Through Inhibition of Protein Phosphatases 1 and 2A. In Harmful and Toxic Algal Blooms, Yasumoto, T., Oshima, Y., Fukuyo, Y., Eds.; Intergovernmental Oceanographic Commissions of UNESCO, 1996; pp. 483-486.
78. Vogelstein, B.; Fearon, E.R.; Hamilton, S.R.; Kern, S.E.; Preisinger, A.C.; Leppert, M.; Nakamura, Y.; White, R.; Smits, A.M.M.; Bos, J.L. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 1988, 319, 525-532.
79. Quintanilla, M.; Brown, K.; Ramsden, M.; Balmain, A. Carcinogen- specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature, 1986, 322, 78-80.
80. Fujiki, H.; Suganuma, M.; Yoshizawa, S.; Kanazawa, H.; Sugimura, Y.; Manam S.; Kahn, S.M.; Jiang, W.; Hoshina, S.; Weinstein, I.B. Codon 61 mutations in the c-Harvey-ras gene in mouse skin tumors induced by 7,12-dimethylbenz[a]anthracene plus okadaic acid class tumor promoters. Mol. Carcinogen, 1989, 2, 184-187.
81. Nelson, M.A.; Futscher, B.W.; Kinsella, T.; Wymer, J.; Bowden, G.T. Detection of mutant Ha-ras genes in chemically initiated mouse skin epidermis before the development of benign tumors. Proc. Natl. Acad. Sci. USA, 1992, 89, 6398-6402.
82. Fujiki, M.; Sugimura, T. New classes of Tumor Promoters: Teleocidin, Aplysiatoxin, and Palytoxin. In Adv. Cancer Res., Klein, G., Weinhouse, S., Eds.; Academic Press INC: London, 1987, vol. 49, pp. 223-264
83. Solt, D.; Farber, E. New principle for the analysis of chemical carcinogenesis. Nature, 1976, 263, 701-703.
84. Peraino, C.; Fry, R.J.M.; Staffeldt, E.; Kisieleski W.E. Effects of varying the exposure to phenobarbital on its enhancement of 2- acetylaminofluorene-induced hepatic tumorigenesis in the rat. Cancer Res., 1973, 33, 2701-2705.
85. Hsu, S.-M.; Raing, L.; Fanger, H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem, 1981, 29, 577-580.
86. Sato, K.; Kitahara, A.; Satoh, K.; Ishikawa, T.; Tatematsu, M; Ito, N. The placental form of glutathione S-transferase as a new marker protein for preneoplasia in rat chemical hepatocarcinogenesis. Gann, 1984, 75, 199-202.
87. Sekijima, M.; Tsutsumi, T.; Yoshida, T.; Harada, T.; Tashiro, F.; Chen, G.; Yu, S.-Z.; Ueno, Y. Enhancement of glutathione Stransferase placental-form positive liver cell foci development by microcystin-LR in aflatoxin B1-initiated rats. Carcinogenesis, 1999, 20, 161-165.
88. Ito, E.; Kondo, F.; Terao, K.; Harada, K.-I. Neoplastic nodular formation in mouse liver induced by repeated intraperitoneal injections of microcystin-LR. Toxicon, 1997, 35, 1453-1457.
89. Kamataki, T. et al. personal communication.
90. Lim, I.K. Erratum to Spectrum of molecular changes during hepatocarcinogenesis induced by DEN and other chemicals in Fischer 344 male rats" Mech. Ageing Dev., 2003, 124, 697-708.
91. Song, K.Y; Lim, I.K.; Park, S.C.; Lee, S.O.; Park, H.S.; Choi, Y.K.; Hyun, B.H. Effect of nodularin on the expression of glutathione S-transferase placental form and proliferating cell nuclear antigen in N-nitrosodiethylamine initiated hepatocarcinogenesis in the male Fischer 344 rat. Carcinogenesis, 1999, 20, 1541-1548.
92. Lim, I.K.; Park, C.C.; Song, K.Y.; Park, T.J.; Lee, M.S., Kim, S.-J., Hyun, B.H. Regulation of selection of liver nodules initiated with N-nitrosodiethylamine and promoted with nodularin injections in Fischer 344 male rats by reciprocal expression of transforming growth factor-β1 and its receptors. Mol. Carcinog., 1999, 26, 83-92.
93. Lim, I.K.; Park, T.J.; Park, S.C.; Yoon, G.; Kwak, C.S.; Lee, M.S.; Song, K.Y.; Choi, Y.K.; Hyun, B.H. Selective left-lobe atrophy by nodularin treatment accompanied by reduced protein phosphatase 1/2A and increased peroxisome proliferation in rat liver. Int. J. Cancer, 2001, 91, 32-40.
94. Lim, I.K.; Park, T.J.; Kwak, J.H.; Paik, W.K. Molecular mechanism of tumor promotion by decreased testosterone during DEN/nodularin induced hepatocarcinogenesis in Fischer 344 male rat. In Liver carcinogenesis, Hepatitis B and C and Hepatocellular cancer; 2nd International Congress on Gastroenterological Carcinogenesis, Berger HG and Link KH, Eds.; Monduzzi Editore International Proceedings Division, Universität Ulm, 1999; pp. 75-82.
95. Park, T.J.; Song, K.Y.; Sohn, S.H.; Lim, I.K. Marked inhibition of testosterone biosynthesis by the hepatotoxin nodularin due to apoptosis of Leydig cells. Mol. Carcinog., 2002, 34, 151-163.
96. Rao, P.V.L.; Gupta, N.; Bhaskar, A.S.B.; Jayaraj, R. Toxins and bioactive compounds from cyanobacteria and their implications on human health. J. Environ. Biol., 2002, 23, 215-224.
97. Briand, J.F.; Jacquet, S.; Bernard, C.; Humbert, J.F. Health hazards for terrestrial vertebrates from toxic cyanobacteria in surface water ecosystems. Vet. Res. 2003, 34, 361-377.
98. Yu, S.-Z. Drinking Water and Primary Liver Cancer. In Primary Liver Cancer, Tang, ZY., Wu, M.C., Xia, S.S., Eds.; Springer- Verlag: Berlin, 1989, pp. 20-30.
99. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Infection with Helicobacter pylori. In IARC Monographs on The Evaluation of Carcinogenic Risks to Humans, IARC: Lyon, 1994, vol. 61, pp. 177-220.
100. Guy, G.R.; Cao, X; Chua, S.P.; Tan, Y.H. Interleukin 1 and tumor necrosis factor activate common multiple protein kinases in human fibroblasts. J. Biol. Chem. 1991, 266, 14343-14352.
101. Guy, G.R.; Chua, S.P.; Wong, N.S.; Ng, S.B.; Tan, Y.H. Okadaic acid mimics multiple changes in early protein phosphorylation and gene expression induced by tumor necrosis factor or interleukin-1. J. Biol. Chem., 1992, 267, 1846-1852.
102. Beutler, B.; Cerami, A. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature, 1986, 320, 584-588.
103. Marino, M.W.; Dunn, A.; Grail, D.; Inglese, M.; Noguchi, Y.; Richards, E.; Jungbluth, A.; Wada, H.; Moore, M.; Willimson, B.; Basu, S.; Old, L.J. Characterization of tumor necrosis factordeficient mice. Proc. Natl. Acad. Sci. USA, 1997, 94, 8093-8098.
104. Suganuma, M.; Okabe, S.; Marino, M.W., Sakai, A.; Sueoka, E.; Fujiki, H. Essential role of tumor necrosis factor α (TNF-α) in tumor promotion as revealed by TNF-α-deficient mice. Cancer Res. 1999, 59, 4516-4518.
105. Sueoka, N.; Sueoka, E.; Miyazaki, Y.; Okabe, S.; Kurosumi, M.; Takayama, S.; Fujiki, H. Molecular pathogenesis of interstitial pneumonitis with TNF-α transgenic mice. Cytokine, 1998, 10, 124-131.
106. Crabtree, J.E.; Shallcross, T.M.; Heatley, R.V.; Wyatt, J.I. Mucosal tumour necrosis factor α and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut, 1991, 32, 1473-1477.
107. Noach, L.A.; Bosma, N.B.; Jansen, J.; Hoek, F.J.; van Deventer, S.J.; Tytgat, G.N. Mucosal tumor necrosis factor-α, interleukin-1α, and interleukin-8 production in patients with Helicobacter pylori infection. Scand. J. Gastroenterol., 1994, 29, 425-429.
108. Suganuma, M.; Kurusu, M.; Okabe, S.; Sueoka, N.; Yoshida, M.; Wakatsuki, Y.; Fujiki, H. Helicobacter pylori membrane protein 1: a new carcinogenic factor of Helicobacter pylori. Cancer Res., 2001, 61, 6356-6359.
109. Suganuma, M.; Kurusu, M.; Suzuki, K.; Nishizono, A.; Murakami, K.; Fujioka, T.; Fujiki, H. New tumor necrosis factor-α-inducing protein released from Helicobacter pylori for gastric cancer progression. J. Cancer Res. Clin. Oncol., 2005, 131, 305-313.
110. Kuzuhara, T.; Suganuma, M.; Kurusu, M.; Fujiki, H. Helicobacter pylori-secreting protein Tipα is a potent inducer of chemokine gene expressions in stomach cancer cells. J. Cancer Res. Clin. Oncol., 2007, 133, 287-296.
111. Suganuma, M.; Yamaguchi, K.; Ono, Y.; Matsumoto, H.; Hayashi, T.; Ogawa, T.; Imai, K.; Kuzuhara, T.; Nishizono, A.; Fujiki, H. TNF-α-inducing protein, a carcinogenic factor secreted from H. pylori, enters gastric cancer cells. Int. J. Cancer, 2008, 123, 117-122.
112. Tsuge, H.; Tsurumura, T.; Utsunomiya, H.; Kise, D.; Kuzuhara, T.; Watanabe, T.; Fujiki, H.; Suganuma, M. Structural basis for the Helicobacter pylori-carcinogenic TNF-α-inducing protein. Biochem. Biophys. Res. Commun., 2009, 388, 193-198.
113. Yoshizawa, S.; Horiuchi, T.; Fujiki, H.; Yoshida, T.; Okuda, T.; Sugimura, T. Antitumor promoting activity of (-)-epigallocatechin gallate, the main constituent of "Tannin" in green tea. Phytother. Res., 1987, 1, 44-47.
114. Fujiki, H.; Suganuma, M. Green tea and cancer prevention. Proc. Jpn. Acad., 2002, 78, Ser B. 263-270.
115. Okabe, S.; Ochiai, Y.; Aida, M.; Park, K.; Kim, S.-J.; Nomura, T.; Suganuma, M.; Fujiki, H. Mechanistic aspects of green tea as a cancer preventive: effect of components on human stomach cancer cell lines. Jpn. J. Cancer Res., 1999, 90, 733-739.
116. Suganuma, M.; Sueoka, E.; Sueoka, N.; Okabe, S.; Fujiki, H. Mechanisms of cancer prevention by tea polyphenols based on inhibition of TNF-α expression. BioFactors, 2000, 13, 67-72.
117. Imai, K.; Suga, K.; Nakachi, K. Cancer-preventive effects of drinking green tea among a Japanese population. Prev. Med., 1997, 26, 769-775.
118. Nakachi, K.; Matsuyama, S.; Miyake, S.; Suganuma, M.; Imai, K. Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. BioFactors, 2000, 13, 49-54.
119. Wang, Z.Y.; Hong, J.Y.; Huang, M.T.; Reuhl, K.; Conney, A.H.; Yang, C.S. Inhibition of N-nitrosodiethylamine-and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mice by green tea and black tea. Cancer Res., 1992, 52, 1943-1947.
120. Gupta, S.; Hastak, K.; Ahmad, N.; Lewin, J.S.; Mukhtar H. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl. Acad. Sci. U.S.A., 2001, 98, 10350-10355.
121. Shimizu, M.; Weinstein, I.B. Modulation of signal transduction by tea catechins and related phytochemicals. Mutat. Res., 2005, 591, 147-160.
122. Fujiki, H.; Suganuma, M.; Imai, K.; Nakachi, K. Green tea: cancer preventive beverage and/or drug. Cancer Lett., 2002, 188, 9-13.
123. Fujiki, H. Green tea: Health benefits as cancer preventive for humans. Chem. Rec., 2005, 5, 119-132.
124. Fujiki, H.; Suganuma, M.; Matsuyama, S.; Miyazaki, K. Cancer prevention with green tea polyphenols for the general population, and for patients following cancer treatment. Curr. Cancer Ther. Rev., 2005, 1, 109-114.
125. Shimizu, M.; Fukutomi, Y.; Ninomiya, M.; Nagura, K.; Kato, T.; Araki, H.; Suganuma, M.; Fujiki, H.; Moriwaki, H. Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol. Biomarkers Prev., 2008, 17, 3020-3025.